Traditional Chinese medicine prescription for treating overweight/obesity type polycystic ovary syndrome

Abstract

The invention discloses a traditional Chinese medicine prescription for treating an overweight / obesity type polycystic ovary syndrome. A basic prescription is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10 to 30 parts of radix codonopsis, 5 to 15 parts of bighead atractylodes rhizome, 5 to 15 parts of poria cocos, 3 to 9 parts of cassia twig, 3 to 9 parts of radix et rhizoma rhei, 5 to 15 parts of herba artemisiae capillariae, 5 to 15 parts of rhizoma alismatis, 5 to 15 parts of rhizoma sparganii, 5 to 15 parts of rhizoma curcumae, 5 to 15 parts of herba epimedii and 3 to 6 parts of prepared liquorice root. The traditional Chinese medicine prescription disclosed by the invention has refined compatibility and basic traditional Chinese medicineraw materials are adopted; metabolism and reproductive-endocrine disorder are considered, the difficult of researching and developing overweight / obesity type polycystic ovary syndrome medicines at present is smoothly solved and a satisfied curative effect is obtained. The prescription is a traditional Chinese medicine compound prescription considering the metabolism and the reproductive-endocrinedisorder; the prescription is simple and the effect is clear; the prescription has a wide popularization prospect in clinical application, and is prepared into various Chinese patent drugs with different preparations so that the prescription is more convenient for patients; the total cost is low so that the financial burden of the patients can be alleviated to the great extent and the medical burden of China is alleviated to a certain extent.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine and specifically refers to a traditional Chinese medicine prescription for treating overweight / obesity polycystic ovary syndrome (PCOS). Background technique [0002] Polycystic ovary syndrome (PCOS) is the most common gynecological endocrine disease among women of childbearing age, and 5%-10% of women of childbearing age worldwide suffer from this disease. A syndrome characterized by anovulatory menstruation, infertility, hyperandrogenism, and insulin resistance, usually with onset around puberty. Symptoms can be manifested as menstrual cycle disorders, usually amenorrhea or oligomenorrhea, which can cause clinical symptoms such as hirsutism, acne, skin seborrheia, and hair loss. A considerable number of patients are combined with obesity, insulin resistance, and lipid metabolism disorders. 33% of PCOS patients are infertile, and long-term complications include endometrial c...

AI Technical Summary

Problems solved by technology

[0006] The purpose of the present invention is to overcome the deficiencies in the existing traditional Chinese and western medicine for the treatment of overweight / obese polycystic ovary syndrome (PCOS), and provide a Chinese medicine prescription for the treatment of overweight / obese polycystic ovary syndrome. On the one hand, it can quickly and effectively reduce the patient's body weight and body mass index, and it is not easy to rebound after weight loss, and it can also improve glucose and lipid metabolism, insulin resistance, etc. disorder, regulate ovarian function, and increase the pregnancy rate of patients with infertility